Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2008-02-15
- Lead Sponsor
- Targeted Genetics Corporation
- Target Recruit Count
- 15
- Registration Number
- NCT00617032
- Locations
- 🇺🇸
UCLA Division of Rheumatology, Los Angeles, California, United States
🇺🇸Denver Arthritis Research Center, Denver, Colorado, United States
🇺🇸Swedish Rheumoatology Research, Seattle, Washington, United States
Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects
- Conditions
- Arthritis, RheumatoidArthritis, PsoriaticAnkylosing Spondylitis
- First Posted Date
- 2005-08-04
- Last Posted Date
- 2009-07-29
- Lead Sponsor
- Targeted Genetics Corporation
- Target Recruit Count
- 120
- Registration Number
- NCT00126724
- Locations
- 🇺🇸
Sun Valley Arthritis Center, Glendale, Arizona, United States
🇺🇸Catalina Pointe Clinical Research, Inc, Tuscon, Arizona, United States
🇺🇸Desert Medical Advances, Palm Desert, California, United States
Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2003-11-25
- Last Posted Date
- 2008-01-28
- Lead Sponsor
- Targeted Genetics Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT00073463
- Locations
- 🇺🇸
UAB-Childrens Health System, Birmingham, Alabama, United States
🇺🇸Stanford University Medical Center, Palo Alto, California, United States
🇺🇸UC San Diego, San Diego, California, United States